Dr. Schiff joined Fund I in September of 1999 and has served as a Managing Partner since 2002. Prior to joining Fund I, Dr. Schiff practiced internal medicine at The New York Presbyterian Hospital where he maintains his position as a Clinical Assistant Professor of Medicine.

Dr. Schiff currently serves as a director of ARMGO Pharma, Inc., Dynova Laboratories, Inc., Planet Technologies, Inc., Sirion Therapeutics, Inc., and SkinMedica, Inc. Previously he served as a director of Adams Respiratory Therapeutics, Inc., ArgiNOx Pharmaceuticals, Inc., Barrier Therapeutics, Inc., Bioenvision, Inc., Cempra Pharmaceuticals, Inc., CardioKine, Inc. and Myogen, Inc.

Dr. Schiff received his M.D. from Cornell University Medical College, his M.B.A. from Columbia University, and his B.S. with honors in Neuroscience from Brown University.

Dennis Purcell
Steven A. Elms
Andrew Schiff
Dov A. Goldstein
Anthony Y. Sun
Brett I.W. Zbar
Josh Bilenker
Aftab R. Kherani
Stacey D. Seltzer
Christine Lee Ha
Justin Sun
Jacob Van Naarden
Lloyd E. Appel
Andrew P. Nicholson
Robert J. Wenzel
Diana Robinson
Jan Hoerrner